Quick Answer
Tevogen Bio Holdings Inc. reported Total Assets of $4.38 million for the year ending 2025.
- Tevogen Bio Holdings Inc. showed an increase of +26.6% in Total Assets from 2024 to 2025.
- This data is from Tevogen Bio Holdings Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2021: $166.8 thousand | Q1 2022: $352.83 million | Q2 2022: $352.98 million | Q3 2022: $354.54 million | Q1 2023: $25.47 million | Q2 2023: $26.38 million | Q3 2023: $26.41 million | Q1 2024: $3.36 million | Q2 2024: $3.31 million | Q3 2024: $4.29 million | Q1 2025: $4.07 million | Q2 2025: $4.27 million | Q3 2025: $4.49 million.
- Over the full 5 years of available data (2021 to 2025), Tevogen Bio Holdings Inc.'s Total Assets has declined by 98.8%.
- Historical annual values: Fiscal year 2025: $4.38 million | Fiscal year 2024: $3.46 million | Fiscal year 2023: $5.51 million | Fiscal year 2022: $357.14 million | Fiscal year 2021: $352.85 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: